chartexchange

XCUR
Exicure, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:18 PM EST
1.03USD-4.630%(-0.05)4,473
After-hoursNov 18, 2026 4:00:30 PM EST
1.04USD+0.971%(+0.01)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Chicago, IL, USA
Previous Close
$1.08
Beta
0.16
52-Week High
$9.48 2025-12-09
52-Week Low
$0.78 2026-11-10
SMA 50
$1.12
SMA 200
$2.44
Avg. Vol 10D
114,590
Avg. Vol 30D
82,659
Avg. Vol 90D
168,643
Relative Vol
0.05
1.84M
14.6700%
3,652
Nov 20, 2026 (1d)
Aug 28, 2024 · 1-for-5 (reverse)
XCUR Profile

exicure, formerly aurasense therapeutics, is developing a new class of immunomodulatory and gene silencing drugs against validated targets. our 3-dimensional, spherical nucleic acid (sna™) architecture unlocks the potential of nucleic acid therapeutics in multiple organs. our lead programs address diseases from inflammatory disorders to oncology. sna constructs overcome one of the most difficult obstacles to nucleic acid therapeutics: safe and effective delivery into cells and tissues. sna constructs exhibit unparalleled transfection efficiency into numerous cell and tissue types including the skin without carriers or transfection agents. moreover, snas can be used as potent immunotherapeutic agents for the treatment of cancer or infectious disease.

XCUR Performance
PeriodPriceDateChangeBeta
1W1.062026-11-12-2.83%-0.213
3M1.452026-08-19-28.97%0.150
6M2.892026-05-19-64.36%0.198
1Y4.742025-11-19-78.27%0.163
2Y5.822024-11-19-82.30%—
5Y69.002021-11-19-98.51%0.750
XCUR Stock Summary

Exicure, Inc. Common Stock (NASDAQ:XCUR) stock price today is $1.03, and today's volume is 4,473. XCUR is down 4.630% today. The 30 day average volume is 82,659. XCUR market cap is $6.74M with 6.55M shares outstanding.